50 employees
Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.
2009
$11M
from 2 investors over 2 rounds
Cerevast Therapeutics raised $11M on March 6, 2015
Investors: Haiyin Venture Partners
Cerevast Therapeutics raised $6.6M on December 12, 2011
Investors: UT Horizon Fund